State of the Heart 2017

Saturday, September 30th, 2017


This program will cover the latest topics in cardiovascular and metabolic disease, guidelines, late-breaking clinical trial results, and will address patient care issues encountered in daily practice. In addition, we will provide a glimpse into the future of cardiovascular and metabolic risk management. We are extremely fortunate to have with us this year an outstanding faculty of international leaders who will provide excellent teaching and opportunity for group discussion surrounding real-world implications of the current evidence.

Slides are available for CCRN members and those who have attended the program.

For more information with regards to becoming a CCRN member, please click HERE



Download Agenda »




Slides Available:

To receive access to the slides, please email Melinda Jones at mjones@ccrnmd.com

Diet, nutrition, and Cardiovascular risk – clearing the fog

Teik Ooi

available

Cardiovascular outcomes trials in diabetes – so much to discuss!

Milan Gupta

available

Anticoagulation and dual antiplatelet therapy:
Is triple therapy necessary?

Shamir Mehta

available

The latest in lipid-lowering: FOURIER, SPIRE
and REVEAL

Jacques Genest

available

Hot off the press: Inflammation as a target for lowering Cardiovascular events

Jacques Genest

available

Obesity management – do we finally have effective options?

Megha Poddar

available

Rivaroxaban in stable vascular disease – is this
the demise of aspirin?

Stuart Connolly

not available

Ongoing clinical trials – what does the future hold?

Narendra Singh

available

How to properly diagnose hypertension and
individualize Blood Pressure targets

Philip McFarlane

not available

Genetics in cardiovascular risk management – keeping it simple

George Thanassoulis

available

How to initiate sacubitirl/valsartan and in which heart failure patient?

Milan Gupta

available

A primer on managing LDL-cholesterol

Robert Hegele

available